CX3CR1-mediated immune networks in sepsis: implications for precision therapy

Area of Science:

• Immunology
• Molecular Biology
• Critical Care Medicine

Background:

• Sepsis is a life-threatening condition with high mortality due to immune dysregulation.
• CX3C chemokine receptor 1 (CX3CR1) plays a critical role in modulating immune cell functions during sepsis.
• CX3CR1 expression levels correlate with sepsis patient survival.

Purpose of the Study:

• To review the molecular mechanisms of CX3CR1 in sepsis-induced immune dysregulation.
• To explore the diverse roles of CX3CR1 in different immune cell subsets.
• To highlight CX3CR1-targeted therapies for precision sepsis treatment.

Main Methods:

• Literature review of studies on CX3CR1 in sepsis.
• Analysis of molecular immunoregulatory networks governed by CX3CR1.
• Examination of preclinical sepsis models involving CX3CR1 modulation.

Main Results:

• CX3CR1 regulates key immune cell functions, including proliferation, differentiation, activation, migration, and survival.
• CX3CR1 exhibits dual pro-inflammatory and anti-inflammatory effects depending on immune cell subset expression.
• Targeted modulation of CX3CR1 in specific immune cells shows therapeutic potential in sepsis models.

Conclusions:

• CX3CR1 is a crucial regulator of immune responses in sepsis.
• Understanding CX3CR1's heterogeneous functions is key to developing effective sepsis therapies.
• Cell type-specific interventions targeting CX3CR1 represent a promising approach for precision sepsis treatment.